• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/69

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

69 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

Abnormal, uncontrolled proliferation and accumulation of one or more hematopoietic cells

Leukemia

Leukemia that is rapidly progressive


Lasts for several days to 6 Mos

Acute Leukemia

Duration of Subacute Leukemia

2-6 Mos

Variable Duration, depending on the age of the px and type of cell involved


Most pxs lived a minimum of 1-2 Years or more

Chronic Leukemia

WBC Count >15,000/uL

Leukemic Leukemia

WBC Count <15,000/uL


With Immature or Abnormal forms of WBCs in peripheral blood

Subleukemic Leukemia

WBC Count of <15,000/uL



With No Immature or Abnormal WBCs in peripheral blood

Aleukemic Leukemia

Leukemia w/ predominance of immature cell types


(blasts & pro stages)

Acute Leukemia

Abrupt Onset of Symptoms

Leukemia w/ predominance of Mature Cells

Chronic Leukemia

Gradual Onset of Symptoms

FAB Criteria for Leukemia Include:

1. Morphology


2. Cytochemistry


3. Immunophenotyping

WHO Criteria for Leukemia

1. Morphology


2. Cytochemistry


3. Immunophenotyping


4. Cytogenetics


5. Clinical Features

FAB Diagnostic Criteria of AML

>/= 30% Blasts

WHO Diagnostic Criteria for AML

>/= 20% Blasts

*Widely Used Criteria

Acute Lymphoblastic Leukemia type in which Lymphoblasts are small & homogenous



Most common type of


Childhood ALL



Best prognosis

L1

Cytoplasm: Scanty


Nuclei: Inconspicuous


Nucleus: Round & Irregular


*Lymphoblasts have a very high N/C Ratio

ALL Type in which Lymphoblasts are larger and variable in size (Large Heterogenous)



Adult Type ALL

L2

Cytoplasm: Abundant, Basophilic


Nuclei: Clefted, W/ nucleoli


ALL Type in which Lymphoblasts are Large but varies little in size (Large Homogenous)



Burkitt Type



Rarest



Prognosis is Poor

L3

W/ Prominent Vacuoles


Cytoplasm: Moderate in quantity, deeply basophilic


Nucleus: Round w/ fine chromatin structure, 1-3 nucleoli

M7

Acute Megakaryocytic Leukemia

1. Large & Small Megakaryoblasts


2. High N/C Ratio


3. Pale Agranular Cytoplasm

Acute Myelomonocytic Leukemia

M4

1. Both Myeloid & Monocytic Cells are present (20% of Total Leukocytes)

M0

Acute Myeloid Leukemia, minimally differentiated

Undiffetentiated Blasts

Acute Monocytic Leukemia,


poorly differentiated


(w/out maturation)

M5a

M2

Acute Myeloid Leukemia


w/ Maturation

Myeloid cells demonstrate maturation beyond blast and promyelocyte stage

M6

Acute Erythroleukemia



Erythremic Myelosis


Di Guglielmo's Syndrome

1. Abnormal prolif of both erythroid & granulocytic precursors


2. May also include abnormal megakaryocytic, and monocytic prolif

Acute Monocytic Leukemia



Well differentiated


(w/ maturation)

M5B

>80% Monocytic Cells

M1

Acute Myeloid Leukemia


w/out Maturation

Acute Promyelocytic Leukemia

M3

1. Translocation in 15 & 17


2. DIC may occur


3. Presence of Faggot Cells w/mass of Auer Rods

Myelodysplastic Syndrome in which there is


1. <1% of blasts in the Peripheral Blood


2. <5% of blasts in BM


3. May or may have ringed sideroblasts

Refractory Anemia or Refractory Cytopenia


(RA/RC)

Myelodysplastic Syndrome in which there is


1. <1 % of blasts in Peripheral Bld


2. <5% of blasts in BM


3. >15% RINGED SIDEROBLAST

Refractory Anemia w/ Ringed Sideroblasts


(RARS)

Myelodysplastic Syndrome in which there is


1. <5% of Blasts in Peripheral Bld


2. 5-20% of blasts in BM


3. May or may have Ringed Sideroblast

Refractory Anemia w/ Excess Blasts (RAEB)

Myelodysplastic Syndrome in which there is


1. >5% of Blasts in Peripheral Bld


2. 20-30% Blasts in BM


3. May or may have Ringed Sideroblast

Refractory Anemia w/ Excess Blasts in Transformation (RAEBIT)

Myelodysplastic Syndrome in which there is


1. <5% Blasts in peripheral bld


2. 5-20% Blasts in BM


3. No ringed sideroblast

Chronic Myelomonocytic Leukemia


(CMML)

Clonal Abnormality in Hematopoietic tissues



Pre-leukemia that can progess to ALL

Myelodysplastic


Syndrome (MDS)/


Dysmyelopoietic


Syndrome

Majority of cases appear to involve B Lymphocytes (Fragile than normal)



Large number of Smudge Cells



More than twice as common in men than in women

Chronic Lymphocytic Leumemia (CLL)

A Lymphoproliferative Disorder

Group of malignant tumors of lymphoid tissue (lymph nodes & spleen)

Lymphoma

Types:


1. Non-Hodgkin's


2. Hodgkin's


3. Burkitt's


4. Sezary Syndrome

Proliferations of malignant lymphocytes (primarily B cells) that are arrested at certain ages of maturation



Classified by Rappaport System

Non-Hodgkin's Lymphoma

Frequent in middle & older age

Presence of Reed-Sternberg Cells (Large Cell w/ large nucleoli)



The cells reacting to neoplasm is predominant rather than the neoplastic cells

Hodgkin's Disease/Lymphoma

Frequent in young & middle aged



Classified According to:


1. Rye Classification


- Histolologic Apperance of Lymphoid Tissue


2. Ann Arbor Classification


- Most widely used staging


-Histoligic type & extent of tissue involvement

Found most often in children of Africa & New Guinea commonly affects jaw & facial bones



EBV isolated from tumor cells plays a role in transforming the B lymphocytes by binding to surface receptors

Burkitt's Lymphoma

Leukemic Phase of


Mycosis Fungoides


affecting predominantly older males



Malignant lymphoma, affecting the skin, involves primarily T lymphocytes

Sezary Syndrome

T Lymphocytes (+) monoclonal abs for CD2, 3, 4

Resemble a medium-sized lymphocyte w/ convoluted ceribriform (brain-like) nucleus, resembling monocyte nucleus

Sezary Cells

(+) Acid Phosphatase Stain using


L Tartaric Acid



Cells are resistant to Inhibition by Tartaric Acid



Characteristic B lymphocytes

Hairy Cell Leukemia

Leukemic Reticuloendotheliosis

Group of acquired malignant disorders that develop from the proliferation of an abnormal pluripotential stem cell

Myeloproliferative Disorders

Stem cell disorder affecting the granulocytic, monocytic, erythrocytic, megakaryocytic cell lines



One arm of Chromosome 22 is


translocated to Chromosome 9 (Philadelphia Chromosome)

Chronic Myelogenous Leukemia/Chronic Granulocytic Leukemia

Indication of


(-)


Philadelphia Chromosome

1. Poorer Prognosis


2. Do not respond Well to therapy

Difference b/w CML & Leukemoid Reaction

CML:


1. High WBC Count


2. Shift to the left w/ blasts, eosinophilia, & basophilia


3. LOW LAP


4. (+) Philadelphia Chromosome

Leukemoid Reaction:


1. High WBC


2. Shift to the left (blasts rare), toxic granulation, dohle bodies


3. HIGH LAP


4. (-) Philadelphia Chromosome

Fibrosis and granulocytic hyperplasia of the BM, w/ granulocytic and megakaryocytic proliferation in the liver & spleen

Myelofibrosis w/ Myeloid Metaplasia

Chronic MPD w/ thrombocytosis in excess of 1000 x 10^9/L w/ spontaneous aggregation of functionally abnormal platelets

Essential


Thrombocythemia

Characterized by an


Inc in RBC, WBC, PLTS

Polycythemia Vera

Panhyperplasia


BM: Panmyelosis


BLD: Pancytosis


Dec EPO, Inc HCT

Above normal Hgb, RBC,


Hct >50%

Polycythemia/Erythrocytosis

Chronic Myeloproliferative Dse


Inc RBCs, WBCs, Plts



D/t Increased RBC Conc, Inc Blood viscosity the px exhibits Ruddy Skin Coloration



Dec EPO

Primary Absolute Polycythemia/


Polycythemia Vera

Appropriate response to Hypoxia



Caused by:


1. Residence @ high altitude


2. Pulmonary & Cardiac Dse



Inc RBCs, WBCs, Plts

Secondary Polycythemia w/ appropriate pxn of EPO

Secondary Polycythemia w/ Inappropriate Pxn of EPO


- Seen in certain tumors


- Normal RBCs, WBCs, Plts

Caused by a dec in the fluid (plasma) portion of the blood



Actual # of RBC not Inc, but the # of cells per unit volume is Inc



Acute Dehy, Stress, Anxiety

Relative Polycythemia

Spurious Polycythemia


- Gaisbock's Syndrome


- Occurs primarily in middle-aged males & may be associated w/ smoking, cardiovascular problems, hypertension & diuretic therapy

Marker for primary granules and Auer rods



Deteriorates, should be done only on fresh specimens



Dark Brown Granules in cytoplasm of granulocytes and monocytes

Myeloperoxidase (MPO)

(+) AML


(-) ALL

Marker for phospholipids & lipids



Can be done on stored specimens



Dark Purple Granules in neutrophil precursors


Lymphoblasts (-)

Sudan Black B (SBB)

(+) AML


(-) ALL

Marker for immature lymphocytes



DNA Polymerase, Immunoperoxidase



Present in 90% of ALL



Differentiate ALL from AML

Terminal


Deoxyribonucleotidyl


Transferase (TdT)

(+) ALL


(-) AML

Marker for glycogen, glycoproteins mucoproteins, & high molecular weight carbohydrates



Activity results in


Bright Fuchsia Pink

Periodic Acid-Schiff

Normally All Blood Cells are (+) exc:


Erythrocytes



L1 & L2:


BLOCK or Chunky PATTERN


L3:


NEGATIVE


Erythroblasts in M6 Leukemia:


POSITIVE

Marker for mature & immature neutrophils & mast cells



Bright Red Granules in Cytoplasm



Specific Esterase



Stable Enzyme, lasts for months

Naphthol AS-D Chloroacetate Esterase

Differentiates


Granulo (+) from Mono (-)

Marker for monocytes, megakaryocytes, & plasma cells



Monocytes are Red-brown



Non-specific Esterase

A-Naphthyl Acetate Esterase

For id of monocytes, promonocytes, monoblasts



Dark Red precipitates in cytoplasm



Non-specific Esterase

A-Naphthyl Butyrate Esterase

Specific = Mono (+) Granulo(-)

Present in all hematopoietic cells & lysosomes



Purple to Red Granules



Can't be stored

Acid Phosphatase

(+) Hairy Cell Leukemia using L (+) Tartaric Acid


(+) Trap


(-) Non T Cell Leukocytes

Excellent marker for


Hairy Cell Leukemia



Purple to Dark Red granules in cytoplasm

Tartrate Resistant Acid Phosphatase

Only Neutrophils contains this activity, stains its ALP



Used to differentiate CML (Low) w/ Leukemoid Reaction (High)

Leukocyte Alkaline Phosphatase

Specimen:


1. Fresh Capillary Bld (Heparin)


EDTA = Falsely Low



100 Cell Count


Scoring:


0 no activity


4 w/ large amount of activity

Binds w/ acid mucopolysaccharides in blood cells



Useful for recognition of mast cells & tissue basophils



Strongly Metachromatic

Toluidine Blue

Color Reactions:


1. MPO


2. Sudan Black B


3. PAS


4. Naphthol AS-D Chloroacetate Esterase


5. A-Naphthyl Acetate Esterase


6. A-Naphthyl Butyrate Esterase


7. ACP


8. Tartrate Resistant ACP

1. MPO


- Dark Brown


2. Sudan Black B


- Dark Purple


3. PAS


- Bright Fuschia Pink


4. Naphthol AS-D Chloroacetate Esterase


- Bright Red


5. A-Naphthyl Acetate Esterase


- Red Brown


6. A-Naphthyl Butyrate Esterase


-Dark Red


7. ACP


-Purple to Red


8. Tartrate Resistant ACP


-Dark Purple to Red

Most common type of microscope used in Hema



Examine Blood Films

Brightfield Microscopy

Ensures an optimum contrast and resolution for the maximum definition of the specimen details by precisely focusing and centering light path and spreading the light uniformly over the field view

KOEHLER/KOHLER ILLUMINATION

Type of Brightfield Microscopy that gives a 3D Image

Interfernce Contrast Microscope

Hoffman:


MODULATION CONTRAST



Nomarski:


DIFF INTERFERENCE CONTRAST

Microscope used for ANA &


T & B-Cell studies

Fluorescence Microscopy

Used for observation of fine ultrastructure of cells w/ magnification of approx.


X100, 000

Electron Microscopy

Used for Manual Platelet Counts

Phase-Contrast Microscopy

Halo

Used for observation of erythrocyte morphology, & differentiates leukocytes

Oil Immersion Microscopy

Solution for Cleaning:


1. Lens Cleaner


2. Alcohol